WELCOME TO SENTINEL PLUS

This medical education website has been funded by AstraZeneca and co-developed with Hull University Teaching Hospitals NHS Trust. This website is intended for UK healthcare professionals only.

I AM NOT A HEALTHCARE PROFESSIONAL

THIS NON-PROMOTIONAL WEBSITE IS INTENDED FOR UK HEALTHCARE PROFESSIONALS ONLY

Logo
☰
  • HOME
  • WHY SENTINEL MATTERS
    • › THE SENTINEL PLUS STORY
    • › PUBLICATIONS AND POSTERS
  • SENTINEL PLUS TOOLKIT
    • ›HEALTHCARE PROFESSIONAL EDUCATION
    • ›GOLD STANDARD PRESCRIBING PRACTICES
    • ›TARGETED ASTHMA REVIEWS
    • ›PATIENT SUPPORT AND EDUCATION
    • ›REAL TIME DATA MONITORING
  • SENTINEL TEAM
  • CONTACT

PUBLICATIONS AND POSTERS

There are a number of publications and congress posters that evidence the impact of the SENTINEL quality improvement project.

Publications

 

01

BMJ Open Respiratory Research (2022): Towards codesign in respiratory care: development of an implementation-ready intervention to improve guideline - adherent adult asthma care across primary and secondary care settings (The SENTINEL Project)

02

ERJ Open Research (2024): Improving asthma care through implementation of the SENTINEL programme: findings from the pilot site

03

NPJ - Primary Care Respiratory Medicine (2024) - Reducing short-acting beta-agonist use in asthma: Impact of national incentives on prescribing practices in England and the findings from SENTINEL Plus early adopter sites

 

Congress posters

 

01

Maintenance and reliever therapy (MART) prescribing in a large UK primary care asthma cohort: implications for BTS/NICE/SIGN Asthma Guideline implementation - Presented at the Primary Care Respiratory Society, Telford, 2025

02

Sentinel QUAL; understanding barriers and facilitators to asthma guideline adoption to improve asthma care - Presented at the Primary Care Respiratory Society, Telford, 2025

03

Impact of the SENTINEL programme on asthma care across six primary care networks in England - presented at the British Thoracic Society WInter Meeting, London, 2025

04

Reducing the environmental impact of asthma and its treatment: findings from the SENTINEL pilot site - presented at the European Respiratory Society Congress, Vienna, Austria, 10 September 2024

  1. first-slide
  2. sec-slide

01

Maintenance and reliever therapy (MART) prescribing in a large UK primary care asthma cohort: implications for BTS/NICE/SIGN Asthma Guideline implementation - Presented at the Primary Care Respiratory Society, Telford, 2025

02

Sentinel QUAL; understanding barriers and facilitators to asthma guideline adoption to improve asthma care - Presented at the Primary Care Respiratory Society, Telford, 2025

03

Impact of the SENTINEL programme on asthma care across six primary care networks in England - presented at the British Thoracic Society WInter Meeting, London, 2025

04

Reducing the environmental impact of asthma and its treatment: findings from the SENTINEL pilot site - presented at the European Respiratory Society Congress, Vienna, Austria, 10 September 2024

  1. first-slide
  2. sec-slide
  3. third-slide
  4. four-slide

GB-76225 | May 2026

SENTINEL Plus is developed with the aim of improving outcomes for asthma patients through identifying and addressing short-acting beta 2 agonist (SABA) over-reliance

SITE PAGES

  • Home
  • Why SENTINEL matters
  • SENTINEL Plus Toolkit
  • SENTINEL Team
  • Contact

LEGAL

  • Terms of use
  • Privacy Policy
  • Cookie Policy

GB-76210 | May 2026

2026 SENTINEL Plus

SENTINEL Plus is a quality improvement framework, providing educational resources. This non-promotional website is funded by AstraZeneca and co-developed with Hull York Medical School and Hull University Teaching Hospitals NHS Trust. Intended for UK Healthcare Professionals Only.